184 Chapter 7 23. Harrison MA, Marfo AFA, Annan A, Ankrah DNA. Access to cardiovascular medicines in low- and middle-income countries: a mini review. Vol. 8, Global Health Research and Policy. BioMed Central Ltd; 2023. 24. Zhao M, Cooney MT, Klipstein-Grobusch K, Vaartjes I, De Bacquer D, De Sutter J, et al. Simplifying the audit of risk factor recording and control: A report from an international study in 11 countries. Eur J Prev Cardiol. 2016;23(11):1202–10. 25. World-Heart-Report-2023. 26. Murray CJL, Aravkin AY, Zheng P, Abbafati C, Abbas KM, Abbasi-Kangevari M, et al. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet. 2020 Oct;396(10258):1223–49. 27. Institute for Health Metrics and Evaluation (IHME). GBD Compare Data Visualization. 201AD [cited 2022 Jun 6]. Global Burden of Disease Compare. Available from: http://www.healthdata.org/gbd/2019 28. Rubinstein AL, Irazola VE, Poggio R, Bazzano L, Calandrelli M, Zanetti FTL, et al. Detection and follow-up of cardiovascular disease and risk factors in the Southern Cone of Latin America: The CESCAS I study. BMJ Open. 2011;1(1):1–6. 29. Fleischer NL, Diez Roux A V. Inequities in cardiovascular diseases in Latin America. Rev Peru Med Exp Salud Publica. 2013;30(4):641–8. 30. Ramos E, Andreis M, Beam C, Bissessar R, Chen D, Cordido M, et al. Equity and Prevention of Cardiovascular Diseases in Latin America and the Caribbean. Glob Heart. 2022 Jun 2;17(1). 31. Lopez-Jaramillo P, Joseph P, Lopez-Lopez JP, Lanas F, Avezum A, Diaz R, et al. Risk factors, cardiovascular disease, and mortality in South America: a PURE substudy. Eur Heart J. 2022 Aug 7;43(30):2841–51. 32. Cífková R, Lánská V, Bruthans J, Mayer O, Kotseva K, Wood D, et al. Blood pressure distribution and control in coronary patients from 24 European countries in the European Society of Cardiology EURoObservational Research Programme European survey of cardiovascular disease prevention and diabetes. EUROASPIRE IV Registry. J Hypertens. 2019;37(10):2015–23. 33. Marzà-Florensa A, Gutierrez L, Gulayin P, Vaartjes I, Grobbee DE, Klipstein-Grobusch K, et al. Risk factor clustering in men and women with CHD in the Southern Cone of Latin America. International Journal of Cardiology Cardiovascular Risk and Prevention. 2023 Mar;16:200172. 34. Rosengren A, Smyth A, Rangarajan S, Ramasundarahettige C, Bangdiwala SI, AlHabib KF, et al. Socioeconomic status and risk of cardiovascular disease in 20 low-income, middle-income, and high-income countries: the Prospective Urban Rural Epidemiologic (PURE) study. Lancet Glob Health. 2019 Jun 1;7(6):e748–60. 35. Marzà-Florensa A, Drotos E, Gulayin P, Grobbee DE, Irazola V, Klipstein-Grobusch K, et al. Prevalence of Cardioprotective Medication Use in Coronary Heart Disease Patients in South America: Systematic review and Meta-Analysis. Glob Heart. 2022;17(1):37. 36. Naderi SH, Bestwick JP, Wald DS. Adherence to Drugs That Prevent Cardiovascular Disease : Meta-analysis on 376 ,162 Patients. AJM. 2012;125(9):882-887.e1. 37. Zhao M, Klipstein-grobusch K, Wang X, Reitsma JB, Zhao D, Grobbee DE, et al. Prevalence of cardiovascular medication on secondary prevention after myocardial infarction in China between 1995-2015 : A systematic review and metaanalysis. 2017;(Ci):1–16. 38. Wekesah FM, Nyanjau L, Kibachio J, Mutua MK, Mohamed SF, Grobbee DE, et al. Individual and household level factors associated with presence of multiple non-communicable disease risk factors in Kenyan adults. BMC Public Health. 2018;18(Suppl 3). 39. Poortinga W. The prevalence and clustering of four major lifestyle risk factors in an English adult population. Prev Med (Baltim). 2007;44(2):124–8. 40. Najafipour H, Afshari M, Rostamzadeh F. Prevalence of multiple coronary artery disease risk factors in kerman: A population-based study in Southeast Iran. Iran J Med Sci. 2018;43(2):140–9. 41. Hong X, Ye Q, He J, Wang Z, Yang H, Qi S, et al. Prevalence and clustering of cardiovascular risk factors: A crosssectional survey among Nanjing adults in China. BMJ Open. 2018;8(6). 42. Yusuf HR, Giles WH, Croft JB, Anda RF, Casper ML. Impact of multiple risk factor profiles on determining cardiovascular disease risk. Prev Med (Baltim). 1998;27(1):1–9. 43. Vynckier P, Kotseva K, Gevaert S, De Bacquer D, De Smedt D. Gender differences in cardiovascular risk factor awareness: Results from the ESC EORP EUROASPIRE V Registry. Int J Cardiol. 2022;352(December 2021):152–7. 44. Neumann FJ, Sechtem U, Banning AP, Bonaros N, Bueno H, Bugiardini R, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Vol. 41, European Heart Journal. Oxford University Press; 2020. p. 407–77. 45. Mehta RH, Bhatt DL, Steg PG, Goto S, Hirsch AT, Liau CS, et al. Modifiable risk factors control and its relationship with 1 year outcomes after coronary artery bypass surgery: Insights from the REACH registry. Eur Heart J. 2008 Dec;29(24):3052–60.
RkJQdWJsaXNoZXIy MTk4NDMw